Skip to Content
Merck
  • Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.

Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.

Journal of pharmaceutical and biomedical analysis (2010-12-15)
D P Elder, D Snodin, A Teasdale
ABSTRACT

This is the latest of a series of reviews focused on the analysis of genotoxic impurities. This review summarises the analytical approaches reported in the literature relating to hydrazine, hydrazines, hydrazides and hydrazones. It is intended to provide guidance for analysts needing to develop procedures to control such impurities, particularly where this is due to concerns relating to their potential genotoxicity. Of particular note is the wide variety of techniques employed, both chromatographic and spectroscopic, with most involving derivatisation. Such a wide variety of options allow the analyst a real choice in terms of selecting the most appropriate technique specific to their requirements. Several generic methodologies, covering the three main analytical approaches; i.e. HPLC (high performance liquid chromatography), GC (gas chromatography) and IC (ion chromatography), are also described.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydrazine, anhydrous, 98%
Sigma-Aldrich
Hydrazine solution, 35 wt. % in H2O
Sigma-Aldrich
Hydrazine solution, 1.0 M in THF
Sigma-Aldrich
Hydrazine solution, 1.0 M in ethanol
Sigma-Aldrich
Hydrazine solution, 1 M in acetonitrile